1	Antivascular	Antivascular	B-NP	JJ	O	2	NMOD	-1
2	actions	action	I-NP	NNS	O	0	ROOT	18	actions
3	of	of	B-PP	IN	O	2	NMOD	-1
4	microtubule-binding	microtubule-binding	B-NP	JJ	B-protein	5	NMOD	-1
5	drugs	drug	I-NP	NNS	I-protein	3	PMOD	-1
6	.	.	O	.	O	2	P	-1

1	Microtubule-binding	Microtubule-binding	B-NP	JJ	O	2	NMOD	-1
2	drugs	drug	I-NP	NNS	O	6	SUB	-1
3	(	(	O	(	O	5	DEP	-1
4	MBD	MBD	B-NP	NN	B-protein	5	DEP	-1
5	)	)	O	)	O	2	NMOD	-1
6	are	be	B-VP	VBP	O	0	ROOT	-1
7	widely	widely	I-VP	RB	O	6	VMOD	-1
8	used	use	I-VP	VBN	O	6	VC	0
9	in	in	B-PP	IN	O	8	VMOD	-1
10	cancer	cancer	B-NP	NN	O	11	NMOD	-1
11	chemotherapy	chemotherapy	I-NP	NN	O	9	PMOD	19	chemotherapy
12	and	and	O	CC	O	6	VMOD	-1
13	also	also	B-ADVP	RB	O	6	VMOD	-1
14	have	have	B-VP	VBP	O	6	VMOD	-1
15	clinically	clinically	B-NP	RB	O	16	AMOD	-1
16	relevant	relevant	I-NP	JJ	O	14	OBJ	-1
17	antiangiogenic	antiangiogenic	I-NP	JJ	O	16	NMOD	3	angiogenic
18	and	and	I-NP	CC	O	16	NMOD	-1
19	vascular-disrupting	vascular-disrupting	I-NP	JJ	O	16	NMOD	6	disrupting
20	properties	property	I-NP	NNS	O	16	NMOD	18	properties
21	.	.	O	.	O	6	P	-1

1	These	These	B-NP	DT	O	3	NMOD	-1
2	antivascular	antivascular	I-NP	JJ	O	3	NMOD	-1
3	actions	action	I-NP	NNS	O	4	SUB	18	actions
4	are	be	B-VP	VBP	O	24	VMOD	-1
5	due	due	B-ADJP	JJ	O	4	PRD	0
6	in	in	B-PP	IN	O	5	AMOD	-1
7	part	part	B-NP	NN	O	6	PMOD	-1
8	to	to	B-PP	TO	O	5	AMOD	-1
9	direct	direct	B-NP	JJ	O	10	NMOD	-1
10	effects	effect	I-NP	NNS	O	8	PMOD	16	effects
11	on	on	B-PP	IN	O	10	NMOD	-1
12	endothelial	endothelial	B-NP	JJ	B-cell_type	13	NMOD	-1
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	-1
14	,	,	O	,	O	24	P	-1
15	and	and	O	CC	O	24	VMOD	-1
16	all	all	B-NP	DT	O	17	NMOD	-1
17	MBDs	MBD	I-NP	NNS	B-protein	24	SUB	-1
18	(	(	O	(	O	23	DEP	-1
19	both	both	O	CC	O	22	NMOD	-1
20	microtubule-stabilizing	microtubule-stabilizing	B-NP	JJ	O	22	NMOD	-1
21	and	and	I-NP	CC	O	22	NMOD	-1
22	microtubule-destabilizing	microtubule-destabilizing	I-NP	JJ	O	23	DEP	-1
23	)	)	O	)	O	17	NMOD	-1
24	inhibit	inhibit	B-VP	VBP	O	0	ROOT	18	inhibit
25	endothelial	endothelial	B-NP	JJ	B-cell_type	27	NMOD	-1
26	cell	cell	I-NP	NN	I-cell_type	27	NMOD	-1
27	proliferation	proliferation	I-NP	NN	O	37	NMOD	1	proliferation
28	,	,	O	,	O	37	P	-1
29	migration	migration	B-NP	NN	O	37	NMOD	14	migration
30	,	,	O	,	O	37	P	-1
31	and	and	O	CC	O	37	NMOD	-1
32	tube	tube	B-NP	NN	O	33	NMOD	-1
33	formation	formation	I-NP	NN	O	37	NMOD	2	formation
34	in	in	B-ADVP	FW	O	33	NMOD	-1
35	vitro	vitro	I-ADVP	FW	O	34	AMOD	-1
36	,	,	O	,	O	37	P	-1
37	actions	action	B-NP	NNS	O	24	OBJ	-1
38	that	that	B-NP	WDT	O	37	NMOD	-1
39	are	be	B-VP	VBP	O	38	SBAR	-1
40	thought	think	I-VP	VBN	O	39	VC	-1
41	to	to	I-VP	TO	O	42	VMOD	-1
42	correspond	correspond	I-VP	VB	O	40	VMOD	-1
43	to	to	B-PP	TO	O	42	VMOD	-1
44	therapeutic	therapeutic	B-NP	JJ	O	46	NMOD	-1
45	antiangiogenic	antiangiogenic	I-NP	JJ	O	46	NMOD	3	angiogenic
46	actions	action	I-NP	NNS	O	43	PMOD	19	actions
47	.	.	O	.	O	24	P	-1

1	In	In	B-PP	IN	O	7	VMOD	-1
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	7	P	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	microtubule-destabilizing	microtubule-destabilizing	I-NP	JJ	O	6	NMOD	-1
6	agents	agent	I-NP	NNS	O	7	SUB	-1
7	cause	cause	B-VP	VBP	O	0	ROOT	16	cause
8	prominent	prominent	B-NP	JJ	O	9	NMOD	-1
9	changes	change	I-NP	NNS	O	7	OBJ	16	changes
10	in	in	B-PP	IN	O	9	NMOD	-1
11	endothelial	endothelial	B-NP	JJ	O	13	NMOD	-1
12	cell	cell	I-NP	NN	O	13	NMOD	-1
13	morphology	morphology	I-NP	NN	O	16	NMOD	-1
14	,	,	O	,	O	16	P	-1
15	an	an	B-NP	DT	O	16	NMOD	-1
16	action	action	I-NP	NN	O	10	PMOD	0
17	associated	associate	B-VP	VBN	O	16	NMOD	16	associated
18	with	with	B-PP	IN	O	17	VMOD	-1
19	rapid	rapid	B-NP	JJ	O	21	NMOD	-1
20	vascular	vascular	I-NP	JJ	O	21	NMOD	-1
21	collapse	collapse	I-NP	NN	O	18	PMOD	6	collapse
22	in	in	B-ADVP	FW	O	17	VMOD	-1
23	vivo	vivo	I-ADVP	FW	O	22	AMOD	-1
24	.	.	O	.	O	7	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	effects	effect	I-NP	NNS	O	6	SUB	16	effects
3	on	on	B-PP	IN	O	2	NMOD	-1
4	endothelial	endothelial	B-NP	JJ	B-cell_type	5	NMOD	-1
5	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	-1
6	occur	occur	B-VP	VBP	O	0	ROOT	-1
7	in	in	B-ADVP	FW	O	6	VMOD	-1
8	vitro	vitro	I-ADVP	FW	O	7	AMOD	-1
9	at	at	B-PP	IN	O	6	VMOD	-1
10	low	low	B-NP	JJ	O	12	NMOD	-1
11	drug	drug	I-NP	NN	O	12	NMOD	-1
12	concentrations	concentration	I-NP	NNS	O	9	PMOD	-1
13	,	,	O	,	O	6	P	-1
14	which	which	B-NP	WDT	O	6	VMOD	-1
15	do	do	B-VP	VBP	O	14	SBAR	-1
16	not	not	I-VP	RB	O	15	VMOD	-1
17	affect	affect	I-VP	VB	O	15	VC	16	affect
18	microtubule	microtubule	B-NP	NN	B-protein	20	NMOD	-1
19	gross	gross	I-NP	JJ	O	20	NMOD	-1
20	morphology	morphology	I-NP	NN	O	17	OBJ	-1
21	,	,	O	,	O	6	P	-1
22	do	do	B-VP	VBP	O	6	VMOD	-1
23	not	not	I-VP	RB	O	22	VMOD	-1
24	cause	cause	I-VP	VB	O	22	VC	16	cause
25	microtubule	microtubule	B-NP	NN	B-protein	26	NMOD	-1
26	bundling	bundling	I-NP	NN	O	29	NMOD	2	bundling
27	or	or	O	CC	O	29	NMOD	-1
28	microtubule	microtubule	B-NP	NN	B-protein	29	NMOD	-1
29	loss	loss	I-NP	NN	O	24	OBJ	6	loss
30	and	and	O	CC	O	6	VMOD	-1
31	do	do	B-VP	VBP	O	6	VMOD	-1
32	not	not	I-VP	RB	O	31	VMOD	-1
33	induce	induce	I-VP	VB	O	31	VC	0
34	cell	cell	B-NP	NN	O	36	NMOD	-1
35	cycle	cycle	I-NP	NN	O	36	NMOD	0
36	arrest	arrest	I-NP	NN	O	42	NMOD	0
37	,	,	O	,	O	42	P	-1
38	apoptosis	apoptosis	B-NP	NN	O	42	NMOD	5	apoptosis
39	,	,	O	,	O	42	P	-1
40	or	or	O	CC	O	42	NMOD	-1
41	cell	cell	B-NP	NN	O	42	NMOD	-1
42	death	death	I-NP	NN	O	33	OBJ	5	death
43	.	.	O	.	O	6	P	-1

1	Rather	Rather	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	it	it	B-NP	PRP	O	4	SUB	-1
4	has	have	B-VP	VBZ	O	29	VMOD	-1
5	been	be	I-VP	VBN	O	4	VC	-1
6	hypothesized	hypothesize	I-VP	VBN	O	5	VC	-1
7	that	that	B-SBAR	IN	O	6	VMOD	-1
8	,	,	O	,	O	7	P	-1
9	at	at	B-PP	IN	O	14	VMOD	-1
10	low	low	B-NP	JJ	O	11	NMOD	-1
11	concentrations	concentration	I-NP	NNS	O	9	PMOD	-1
12	,	,	O	,	O	14	P	-1
13	MBDs	MBD	B-NP	NNS	B-protein	14	SUB	-1
14	produce	produce	B-VP	VBP	O	7	SBAR	0
15	more	more	B-NP	JJR	O	17	NMOD	-1
16	subtle	subtle	I-NP	JJ	O	17	NMOD	-1
17	effects	effect	I-NP	NNS	O	14	OBJ	16	effects
18	on	on	B-PP	IN	O	17	NMOD	-1
19	microtubule	microtubule	B-NP	NN	B-protein	20	NMOD	-1
20	dynamics	dynamic	I-NP	NNS	O	18	PMOD	-1
21	,	,	O	,	O	14	P	-1
22	block	block	B-VP	VBP	O	14	VMOD	0
23	critical	critical	B-NP	JJ	O	26	NMOD	0
24	cell	cell	I-NP	NN	O	26	NMOD	-1
25	signaling	signaling	I-NP	NN	O	26	NMOD	0
26	pathways	pathway	I-NP	NNS	O	22	OBJ	0
27	,	,	O	,	O	4	P	-1
28	and	and	O	CC	O	4	VMOD	-1
29	prevent	prevent	B-VP	VBP	O	0	ROOT	18	prevent
30	the	the	B-NP	DT	O	31	NMOD	-1
31	microtubules	microtubule	I-NP	NNS	B-protein	29	OBJ	-1
32	from	from	B-PP	IN	O	29	VMOD	-1
33	properly	properly	B-ADVP	RB	O	34	VMOD	-1
34	interacting	interact	B-VP	VBG	O	32	PMOD	15	interacting
35	with	with	B-PP	IN	O	34	VMOD	-1
36	transient	transient	B-NP	JJ	O	38	NMOD	-1
37	subcellular	subcellular	I-NP	JJ	O	38	NMOD	-1
38	assemblies	assembly	I-NP	NNS	O	50	NMOD	-1
39	(	(	O	(	O	45	DEP	-1
40	focal	focal	B-NP	JJ	O	41	NMOD	-1
41	adhesions	adhesion	I-NP	NNS	O	44	NMOD	-1
42	and	and	I-NP	CC	O	44	NMOD	-1
43	adherens	adheren	I-NP	NNS	O	44	NMOD	-1
44	junctions	junction	I-NP	NNS	O	45	DEP	-1
45	)	)	O	)	O	38	NMOD	-1
46	whose	whose	B-NP	WP$	O	50	NMOD	-1
47	subsequent	subsequent	I-NP	JJ	O	50	NMOD	-1
48	stabilization	stabilization	I-NP	NN	O	50	NMOD	6	stabilization
49	and/or	and/or	I-NP	CC	O	50	NMOD	-1
50	maturation	maturation	I-NP	NN	O	35	PMOD	2	maturation
51	are	be	B-VP	VBP	O	29	VMOD	-1
52	required	require	I-VP	VBN	O	51	VC	17	required
53	for	for	B-PP	IN	O	52	VMOD	-1
54	cell	cell	B-NP	NN	O	55	NMOD	-1
55	motility	motility	I-NP	NN	O	58	NMOD	14	motility
56	and	and	O	CC	O	58	NMOD	-1
57	cell-cell	cell-cell	B-NP	JJ	O	58	NMOD	-1
58	interactions	interaction	I-NP	NNS	O	53	PMOD	15	interactions
59	.	.	O	.	O	29	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	review	review	I-NP	NN	O	3	SUB	-1
3	will	will	B-VP	MD	O	0	ROOT	-1
4	focus	focus	I-VP	VB	O	3	VC	-1
5	on	on	B-PP	IN	O	4	VMOD	-1
6	recent	recent	B-NP	JJ	O	7	NMOD	-1
7	studies	study	I-NP	NNS	O	5	PMOD	-1
8	to	to	B-VP	TO	O	9	VMOD	-1
9	define	define	I-VP	VB	O	7	NMOD	-1
10	the	the	B-NP	DT	O	12	NMOD	-1
11	molecular	molecular	I-NP	JJ	O	12	NMOD	-1
12	mechanisms	mechanism	I-NP	NNS	O	9	OBJ	-1
13	for	for	B-PP	IN	O	12	NMOD	-1
14	the	the	B-NP	DT	O	16	NMOD	-1
15	antivascular	antivascular	I-NP	JJ	O	16	NMOD	-1
16	actions	action	I-NP	NNS	O	13	PMOD	18	actions
17	of	of	B-PP	IN	O	16	NMOD	-1
18	the	the	B-NP	DT	O	19	NMOD	-1
19	MBDs	MBD	I-NP	NNS	B-protein	21	NMOD	-1
20	,	,	O	,	O	21	P	-1
21	information	information	B-NP	NN	O	17	PMOD	-1
22	that	that	B-NP	WDT	O	21	NMOD	-1
23	could	could	B-VP	MD	O	22	SBAR	-1
24	be	be	I-VP	VB	O	23	VC	-1
25	useful	useful	B-ADJP	JJ	O	24	PRD	-1
26	in	in	B-PP	IN	O	25	AMOD	-1
27	the	the	B-NP	DT	O	30	NMOD	-1
28	identification	identification	I-NP	NN	O	30	NMOD	-1
29	or	or	I-NP	CC	O	30	NMOD	-1
30	design	design	I-NP	NN	O	26	PMOD	-1
31	of	of	B-PP	IN	O	30	NMOD	-1
32	agents	agent	B-NP	NNS	O	34	NMOD	-1
33	whose	whose	B-NP	WP$	O	34	NMOD	-1
34	actions	action	I-NP	NNS	O	31	PMOD	-1
35	more	more	B-VP	RBR	O	36	AMOD	-1
36	selectively	selectively	I-VP	RB	O	37	VMOD	-1
37	target	target	I-VP	VB	O	34	NMOD	16	target
38	the	the	B-NP	DT	O	40	NMOD	-1
39	tumor	tumor	I-NP	NN	O	40	NMOD	-1
40	vasculature	vasculature	I-NP	NN	O	37	OBJ	-1
